Developing anti-TDE vaccine for sensitizing cancer cells to treatment and metastasis control | npj Vaccines
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research is underway on a vaccine that targets tumor-derived exosomes to sensitize cancer cells to treatment and control metastasis. The approach is part of a broader exploration of vaccine strategies for various types of cancer, including colorectal and liver cancer. Studies are investigating the role of exosomes in cancer immunity and metastasis, with some focusing on targeted inhibition of tumor-derived exosomes as a potential therapeutic option.
Full coverage
1234